Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epacadostat, Pembrolizumab, and Azacitidine in Chemo-refractory Metastatic Colorectal Cancer
NCT03182894Phase 2Withdrawn
- Sponsor
- James J. Lee
- Start
- Sep 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epacadostat in metastatic colorectal cancer (mCRC), sponsored by James J. Lee. Planned start Sep 2018; status: withdrawn.
02
Drugs
epacadostat
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT03182894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03182894.